e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Biomarkers and other new methods for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Volatile organic compounds in lung cancer patients before and after tumour resection
K. Darwiche, I. Kurth, J. I. Baumbach, U. Sommerwerck, H. Teschler, L. Freitag (Essen, Saarbruecken, Germany)
Source:
Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Session:
Biomarkers and other new methods for lung cancer
Session type:
Thematic Poster Session
Number:
2790
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Darwiche, I. Kurth, J. I. Baumbach, U. Sommerwerck, H. Teschler, L. Freitag (Essen, Saarbruecken, Germany). Volatile organic compounds in lung cancer patients before and after tumour resection. Eur Respir J 2011; 38: Suppl. 55, 2790
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Volatile organic compounds (VOC) in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010
Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
Fitness before lung resection in lung cancer patients
Source: CME Online 2010
Year: 2010
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Early recurrence in complete resected non-small cell lung cancer patients
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
Source: Eur Respir Rev 2013; 22: 565-576
Year: 2013
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
Surgical treatment for lung metastases in patients with colorectal cancer
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007
Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Temozolomide in the treatment of brain metastases in lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003
Combined resection of adjacent organ in NSCLC
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007
Long-term survival after surgical resection for non-small cell lung cancer
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Brain metastases in lung cancer patients
Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients.
Year: 2019
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
The survival in elderly patients after resection of lung cancer
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
Treatment modalities in lung cancer patients with brain metastasis
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Fitness for radical treatment of lung cancer patients
Source: Breathe 2011; 7: 221-228
Year: 2011
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept